Show simple item record

2021-06-21Berichte und sonstige Texte DOI: 10.25646/8671
Application of the Euroimmun anti-SARS-CoV-2-S1-IgG ELISA antibody test to dried blood spots
dc.contributor.authorRobert Koch-Institut
dc.date.accessioned2021-06-22T07:24:55Z
dc.date.available2021-06-22T07:24:55Z
dc.date.issued2021-06-21none
dc.identifier.urihttp://edoc.rki.de/176904/8415
dc.description.abstractThe qualitative Euroimmun anti-SARS-CoV-2-S1-IgG ELISA antibody test has been most commonly used in the analysis of serum samples since early 2020. In the population-based seroepidemiological study 'CORONA-MONITORING bundesweit' (RKI-SOEP study) [1], however, it is used to analyse dried blood spots (DBS). A method study was therefore conducted comparing serum with dried blood, embedded in the 'CORONA-MONITORING lokal' study [2]. This method study comprised 276 individuals who had participated both in the baseline survey in May/June 2020 and in the follow-up survey of the study 'CORONA-MONITORING lokal' in October 2020. The sample was made up of individuals who either had a positive or indeterminate IgG test result in serum measurements at the time of the baseline survey (n = 265) or had a negative test result but reported a positive PCR test before the baseline survey in the questionnaire (n = 11).eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleApplication of the Euroimmun anti-SARS-CoV-2-S1-IgG ELISA antibody test to dried blood spotsnone
dc.typereport
dc.identifier.urnurn:nbn:de:kobv:0257-176904/8415-7
dc.identifier.doihttp://dx.doi.org/10.25646/8671
dc.type.versionpublishedVersionnone
local.edoc.type-nameBerichte und sonstige Texte
local.edoc.rki-departmentEpidemiologie und Gesundheitsmonitoringnone

Show simple item record